Recordati Rare Diseases Australia Pty. Ltd.
Manufacturer / marketing-authorisation holder
Recordati Rare Diseases Australia Pty. Ltd. — 24 products across 1 markets, 16 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
Recordati Rare Diseases Australia Pty. Ltd. — 24 productos en 1 mercados, 16 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
Recordati Rare Diseases Australia Pty. Ltd. —— 共 24 个产品，覆盖 1 个市场、16 个品牌名。产品按国家分组；品牌名链到品牌页，成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」，不一定是生产工厂。
24 products · 1 markets · 16 brand names
24 productos · 1 mercados · 16 marcas
24 个产品 · 1 个市场 · 16 个品牌名
Products by country
AU
Source: compliance.health.gov.au
| Brand | Active ingredient(s) | Form |
|---|---|---|
| CYSTADANE betaine 1g/g oral powder bottle | Betaine | powder |
| CYSTADROPS - mercaptamine (cysteamine) (as hydrochloride) 3.8 mg/mL eye drops solution vial | Mercaptamine | liquid |
| Carbaglu carglumic acid 200 mg dispersible tablets tube | Carglumic Acid | tablet |
| Cosmegen dactinomycin (actinomycin D) 0.5mg injection | Dactinomycin | injection |
| Cystadane | Betaine | powder |
| ISTURISA osilodrostat (as phosphate) 5 mg film-coated tablet blister pack | 奥唑司他 | tablet |
| ISTURISA osilodrostat (as phosphate) 5 mg film-coated tablet blister pack | 奥唑司他 | tablet |
| Isturisa | 奥唑司他 | tablet |
| Isturisa | 奥唑司他 | tablet |
| PEDEA ibuprofen 10 mg/2 mL solution for intravenous infusion 2 mL glass ampoule | 布洛芬 | injection |
| QARZIBA dinutuximab beta 4.5 mg/mL concentrate for solution for infusion, 20 mg/4.5 mL vial | Dinutuximab Beta | liquid |
| SIGNIFOR LAR pasireotide 20 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack | Pasireotide Embonate | unknown |
| SIGNIFOR LAR pasireotide 20 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack | Pasireotide Embonate | unknown |
| SIGNIFOR LAR pasireotide 20 mg (as embonate) modified release powder for injection vial and 2 mL diluent in prefilled syringe composite pack | Pasireotide Embonate | unknown |
| SIGNIFOR pasireotide 300 microgram/1 mL (as diaspartate) solution for injection ampoule | Pasireotide Diaspartate | injection |
| SIGNIFOR pasireotide 600 microgram/1 mL (as diaspartate) solution for injection ampoule | Pasireotide Diaspartate | injection |
| SIGNIFOR pasireotide 900 microgram/1 mL (as diaspartate) solution for injection ampoule | Pasireotide Diaspartate | injection |
| SYLVANT siltuximab (rmc) 100mg powder for injection vial | 司妥昔单抗 | injection |
| SYLVANT siltuximab (rmc) 100mg powder for injection vial | 司妥昔单抗 | injection |
| Signifor LAR | Pasireotide Embonate | injection |
| Signifor LAR | Pasireotide Embonate | injection |
| Signifor LAR | Pasireotide Embonate | injection |
| Sylvant | 司妥昔单抗 | injection |
| Sylvant | 司妥昔单抗 | injection |